©2024 Stanford Medicine
Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors
Not Recruiting
Trial ID: NCT03109262
Purpose
This clinical trial studies how well yttrium-90 (Y90) glass microspheres positron emission
tomography (PET)/computed tomography (CT) works in imaging patients with liver tumors .
Images produced by PET/CT may provide better information about the distribution of particles,
such as Y90 glass microspheres, delivered for selective internal radiation therapy (SIRT) as
compared to regular medical care images useing technetium Tc-99m albumin-aggregated single
photon emission computed tomography (SPECT)/CT images.
Official Title
High Quality Imaging and Dosimetry of Yttrium-90 (90Y) SIRT Using a Digital PET/CT
Stanford Investigator(s)
Andrei Iagaru
Professor of Radiology (Nuclear Medicine)
David S. Wang, MD
Clinical Associate Professor, Radiology
Eligibility
Inclusion Criteria:
- Patient provides written informed consent
- Patient is referred for 90Y SIRT radioembolization of liver tumor(s)
- Patient is capable of complying with study procedures
- Patient is able to remain still for duration of imaging procedure (approximately 30
minutes total for digital PET/CT)
Exclusion Criteria:
- Patient is pregnant or nursing
Intervention(s):
procedure: Computed Tomography (CT)
procedure: Positron Emission Tomography (PET)
device: 90-Yttrium (Y-90) Glass Microspheres
diagnostic test: Technetium 99mTc albumin aggregated (99mTc-MAA)
procedure: Single-photon emission computerized tomography (SPECT) scan
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Risa Jiron
650-736-1598